Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EverSlim vs LillyDirect Foundayo

EverSlim
Graded #54

Higher grade

vs+8.599999999999994
LillyDirect Foundayo
Graded #174

Lower grade

The verdict

EverSlim takes it — 75.8/100 to 67.2/100.

EverSlim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EverSlim is a US telehealth program offering doctor-prescribed, compounded GLP-1 weight-loss medication delivered to your door.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEverSlim +17
89
72
Dose & formulationEverSlim +13
72
59
Clinical oversightLillyDirect Foundayo +2
76
78
Labs & monitoringEverSlim +1
53
52
FulfillmentEverSlim +17
97
80
Contract termsEven
55
55
EverSlim · left barLillyDirect Foundayo · right bar

The numbers

MetricEverSlimLillyDirect Foundayo
WeighScore75.8/10067.2/100
GradeCC
Scorecard rank#54#174
Semaglutide$127/moNot disclosed
Tirzepatide$183/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
EverSlim

Graded #54 · C

Strengths

  • Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
  • Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
  • Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
  • Offers both semaglutide and tirzepatide, plus care-team messaging between visits.

Where it loses points

  • Compounded medications are not FDA-approved, and no brand-name Wegovy, Ozempic, or Zepbound options are offered.
  • Site discloses that some imagery and content may be AI-generated and some ad figures are actors, not real clinicians.
  • Newer brand with limited independent, third-party review history.
LillyDirect Foundayo

Graded #174 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard